Mark Leschly's Net Worth

$365 Million

Estimate Recalculated Feb 22, 2024 06:29PM EST

Who is Mark Leschly?

Mark Leschly has an estimated net worth of $365 Million. This is based on reported shares across multiple companies, which include Anacor Pharmaceuticals, Inc., NGM BIOPHARMACEUTICALS INC, TERCICA INC, Everyday Health, Inc., Cara Therapeutics, Inc., ON24 INC., Vanda Pharmaceuticals Inc., INOTEK PHARMACEUTICALS CORP, ChargePoint Holdings, Inc., IntraLinks Holdings, Inc., SENOMYX INC, ReachLocal Inc, NephroGenex, Inc., BLUEFLY INC, NITROMED INC, ADVANCIS PHARMACEUTICAL CORP, and VERENIUM CORP.

SEC CIK

Mark Leschly's CIK is 0001120545

Past Insider Trading and Trends

2004 was Mark Leschly's most active year for acquiring shares with 15 total transactions. Mark Leschly's most active month to acquire stocks was the month of April. 2004 was Mark Leschly's most active year for disposing of shares, totalling 33 transactions. Mark Leschly's most active month to dispose stocks was the month of March. 2010 saw Mark Leschly paying a total of $22,263,226.40 for 24,818,265 shares, this is the most they've acquired in one year. In 2017 Mark Leschly cashed out on 6,290,503 shares for a total of $81,776,539.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Anacor Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-794.00
$99.25
-$78,804.50
0
Jun 24
Form 4
794
794
Jun 9
Form 4
-100.00%
-13.07K
$22.50
-$294,007.50
0
Aug 27
Form 4/A
13.07K
13.07K
Feb 3
Form 4
0
0
May 29
Form 4
0
0
Jun 6
Form 4
0
0
May 30
Form 4
0
0
May 25
Form 4
0
0
Mar 31
Form 4
5.62M
$5.00
5.62M
Nov 30
Form 3
0
0
No matching records found

NGM BIOPHARMACEUTICALS INC (NGM) Snapshot price: $1.43

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 8
Form 4
0
0
May 20
Form 4
0
0
May 15
Form 4
3.77M
3.77M
Apr 8
Form 3
0
0
No matching records found

TERCICA INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.01M
$9.00
-$27,074,556.00
0
Oct 16
Form 4
3.33K
3.33K
May 20
Form 4
0
0
May 24
Form 4
0
0
Jun 6
Form 4
0
0
Jun 1
Form 4
+12.19%
325K
$8.00
$2,600,000.00
2.99M
Feb 11
Form 4
2.67M
$9.00
$6,003,000.00
2.67M
Mar 22
Form 3/A
0
0
Form 3
0
0
No matching records found

Everyday Health, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-4.57M
$10.09
-$46,175,132.67
0
Dec 3 - Dec 5
Form 4
+290.11%
4.46M
$13.02
-$1,199,402.40
6M
Apr 2
Form 3
0
0
No matching records found

Cara Therapeutics, Inc. (CARA) Snapshot price: $0.532

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+16.30%
500K
$18.19
$9,095,700.00
3.57M
Mar 31
Form 4
+14.99%
400K
$4.87
$1,949,202.91
3.07M
Mar 16 - Mar 17
Form 4
2.67M
$11.00
$2,483,998.00
2.67M
Feb 5
Form 3
0
0
No matching records found